J. Munoz et al., VARIATIONS IN THE ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND CHRONIC RESPIRATORY INSUFFICIENCY, Revista Clinica Espanola, 194(12), 1994, pp. 1018-1022
Maintained hypoxia has been reported to induce inactivation of the Ang
iotensin Converting Enzyme (ACE). Variations have also been observed i
n patients with chronic obstructive pulmonary disease (COPD) who have
chronic hypoxemia and loss of the vascular endothelium. Objectives: 1)
to determine serum ACE activity in patients with COPD treated with an
d without continuous ambulatory oxygen therapy (CAOT); 2) to verify wh
ether there is a correlation between ACE and any hematological, spirom
etric or gasometric parameter. Methods: fifty-eight patients fulfillin
g clinical and spirometric parameters of COPD were studied. Patients w
ere assigned to two groups of therapy: A) Group A, without Continuous
Ambulatory Oxygen Therapy (CAOT): 31 males and 1 female (mean age: 64.
8+/-6.52). B) Group B (with CAOT): 23 males and 3 females (mean age ye
ars: 63.76+/-8 years). The following procedures were performed: spirom
etry, gasometry, blood chemistry, and serum ACE measurements by means
of a radioenzymatic assay. The Student ''t'' test with the Bonferroni
correction and Pearson regression analysis were used for the statistic
al analysis. Results: significant differences were observed for ACE va
lues between Group A and Group B: 42.81+/-11.30 vs. 33.40+/-9.43 mumol
/min/l, with a p value of 0.001, and also between Group B and referenc
e values: 33.40+/-9.43 vs. 39.70+/-9.65 mumol/min/l, with a p value of
0,002. No differences were observed between Group A and reference val
ues. No correlations wer found between ACE and any of the variables st
udied. Conclusions: ACE was not decreased in all patients with COPD. A
CE was decreased only in patients with COPD and respiratory insufficie
ncy requiring CAOT and with advanced disease. This results can be corr
elated with changes in vascular endothelium, pulmonar parenchyma and m
etabolism. It could be a marker of poor prognosis or advanced disease.